Diabetic eye disease: how can it be prevented?
Broadbent
D M
DM
Liverpool Diabetes Eye Centre, Royal Liverpool University Hospital.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000804:Angiotensin II / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D003930:Diabetic Retinopathy / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control*; D006801:Humans; D006943:Hyperglycemia / Q000150:complications; D053685:Laser Therapy; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D000804:Angiotensin II